Skip to main content
Log in

Synthesis and pharmacological activity of (2-chloroethoxy-4′-dimethylaminophenyl)phosphorylacetic acid hydrazide (CAPAH) and its metabolite (N-acetyl derivative)

  • Published:
Pharmaceutical Chemistry Journal Aims and scope

The new compound (2-chloroethoxy-4′-dimethylaminophenyl)phosphorylacetic acid N-acetylhydrazide (II) was synthesized. Compound II was proposed as a metabolite of (2-chloroethoxy-4′-dimethylaminophenyl)phosphorylacetic acid hydrazide (CAPAH, I), a drug possessing nootropic activity. The psychotropic and antiarrhythmic properties of II were compared with those of I. It was established that II did not possess nootropic and antidepressant activities although its antiarrhythmic properties were more pronounced. It was suggested that the C(O)CH3 fragment, being a substituent on the hydrazide in II, decreased penetration of the compound through the blood―brain barrier, which could explain the absence of psychotropic activity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. I. I. Semina, N. A. Tikhonova, A. Z. Baichurina, et al., Vestn. Ross. Akad. Med. Nauk, No. 3, 32-36 (1999).

  2. I. I. Semina, E. V. Shilovskaya, R. I. Tarasova, et al., Khim.-farm. Zh., 36, No. 4, 3-6 (2002).

    Google Scholar 

  3. R. I. Tarasova, O. V. Voskresenskaya, I. I. Semina, et al., Khim.-farm. Zh., 36, No. 6, 17-20 (2002).

    Google Scholar 

  4. G. G. Nikolaeva, Author's Abstract of a Candidate Dissertation in Medical Sciences, Kazan (1998).

  5. R. I. Tarasova, N. A. Blyukherova, O. M. Kalina, G. F. Rzhevskaya, RF Pat. No. 2,062,099 (1992); Byull. Izobret., No. 17 (1996).

  6. R. I. Tarasova, I. I. Semina, V. A. Pavlov, V. V. Moskva, RF Pat. No. 2,141,961 (1999); Byull. Izobret., No. 33 (2000).

  7. D. Yu. Rusakov, A. V. Valʹdman, Farmakol. Toksikol., 46, No. 5, 107–111 (1983).

    PubMed  CAS  Google Scholar 

  8. N. V. Kaverina, Z. P. Senova, Methodical Recommendations for Experimental (Preclinical) Study of Drugs Proposed for Clinical Trials as Agents for Prevention and Treatment of Cardiac Rhythm Disruptions [in Russian], Meditsina, Moscow (1981), pp. 3–12.

    Google Scholar 

  9. V. V. Gorbunova, N. P. Gorbunov, Farmakol. Toksikol., No. 3, 48-50 (1983).

  10. E. I. Gendenshtein, Ya. V. Kostin, N. N. Markelova, et al., Farmakol. Toksikol., 53, No. 4, 28-30 (1990).

    PubMed  CAS  Google Scholar 

  11. E. I. Gendenshtein, S. M. Lemkina, L. N. Sernov, Farmakol. Toksikol., No. 6, 83-86 (1985).

Download references

Acknowledgments

The work was sponsored by NIOKR-RFFI [R&D RFBR] (Grant 03-04-96272).

Author information

Authors and Affiliations

Authors

Additional information

Translated from Khimiko-farmatsevticheskii Zhurnal, Vol. 47, No. 1, pp. 29-31, January, 2013.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Semina, I.I., Balashov, V.P., Kurmysheva, T.V. et al. Synthesis and pharmacological activity of (2-chloroethoxy-4′-dimethylaminophenyl)phosphorylacetic acid hydrazide (CAPAH) and its metabolite (N-acetyl derivative). Pharm Chem J 47, 28–30 (2013). https://doi.org/10.1007/s11094-013-0889-2

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11094-013-0889-2

Keywords

Navigation